Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on July 27, 2023. The filing serves to distribute a press release dated July 27, 2023, to U.S. investors pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Financial Metrics
The provided filing text does not contain specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are disclosed in this document.
Material Changes
The filing text does not provide details regarding material changes versus prior periods. The document acts solely as a cover for the attached press release (Exhibit 99.1) without summarizing its content.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are contained within the referenced press release, which is not included in the input text.
Key Facts for Investor Verification
- Verify the content of the press release dated July 27, 2023 (Exhibit 99.1), as the Form 6-K itself contains no operational or financial details.
- Confirm the specific announcement made by CEO André Choulika on the report date.
- Review the company's Form 20-F for the most recent audited financial statements, as this filing does not provide them.